Search Results - "Portela Catani, João Paulo"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B by Portela Catani, João Paulo, Ysenbaert, Tine, Smet, Anouk, Vuylsteke, Marnik, Vogel, Thorsten U, Saelens, Xavier

    Published in PloS one (23-01-2023)
    “…Influenza B viruses (IBV) are responsible for a considerable part of the burden caused by influenza virus infections. Since their emergence in the 1980s, the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models by Schepens, Bert, van Schie, Loes, Nerinckx, Wim, Roose, Kenny, Van Breedam, Wander, Fijalkowska, Daria, Devos, Simon, Weyts, Wannes, De Cae, Sieglinde, Vanmarcke, Sandrine, Lonigro, Chiara, Eeckhaut, Hannah, Van Herpe, Dries, Borloo, Jimmy, Oliveira, Ana Filipa, Catani, João Paulo Portela, Creytens, Sarah, De Vlieger, Dorien, Michielsen, Gitte, Marchan, Jackeline Cecilia Zavala, Moschonas, George D, Rossey, Iebe, Sedeyn, Koen, Van Hecke, Annelies, Zhang, Xin, Langendries, Lana, Jacobs, Sofie, Ter Horst, Sebastiaan, Seldeslachts, Laura, Liesenborghs, Laurens, Boudewijns, Robbert, Thibaut, Hendrik Jan, Dallmeier, Kai, Velde, Greetje Vande, Weynand, Birgit, Beer, Julius, Schnepf, Daniel, Ohnemus, Annette, Remory, Isabel, Foo, Caroline S, Abdelnabi, Rana, Maes, Piet, Kaptein, Suzanne J F, Rocha-Pereira, Joana, Jochmans, Dirk, Delang, Leen, Peelman, Frank, Staeheli, Peter, Schwemmle, Martin, Devoogdt, Nick, Tersago, Dominique, Germani, Massimiliano, Heads, James, Henry, Alistair, Popplewell, Andrew, Ellis, Mark, Brady, Kevin, Turner, Alison, Dombrecht, Bruno, Stortelers, Catelijne, Neyts, Johan, Callewaert, Nico, Saelens, Xavier

    Published in Science translational medicine (24-11-2021)
    “…Broadly neutralizing antibodies are an important treatment for individuals with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome…”
    Get more information
    Journal Article
  7. 7

    Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine by Zhong, Zifu, Portela Catani, João Paulo, Mc Cafferty, Séan, Couck, Liesbeth, Van Den Broeck, Wim, Gorlé, Nina, Vandenbroucke, Roosmarijn E, Devriendt, Bert, Ulbert, Sebastian, Cnops, Lieselotte, Michels, Johan, Ariën, Kevin K, Sanders, Niek N

    Published in Vaccines (Basel) (23-08-2019)
    “…To combat emerging infectious diseases like Zika virus (ZIKV), synthetic messenger RNAs (mRNAs) encoding viral antigens are very attractive as they allow a…”
    Get full text
    Journal Article
  8. 8

    Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs by Zhong, Zifu, McCafferty, Séan, Opsomer, Lisa, Wang, Haixiu, Huysmans, Hanne, De Temmerman, Joyca, Lienenklaus, Stefan, Portela Catani, João Paulo, Combes, Francis, Sanders, Niek N.

    Published in Molecular therapy (07-04-2021)
    “…Synthetic mRNAs are an appealing platform with multiple biomedical applications ranging from protein replacement therapy to vaccination. In comparison with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma by Catani, João Paulo Portela, Medrano, Ruan F.V, Hunger, Aline, Del Valle, Paulo, Adjemian, Sandy, Zanatta, Daniela Bertolini, Kroemer, Guido, Costanzi-Strauss, Eugenia, Strauss, Bryan E

    Published in Translational oncology (01-12-2016)
    “…Abstract Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but…”
    Get full text
    Journal Article
  12. 12

    Near future of tumor immunology: Anticipating resistance mechanisms to immunotherapies, a big challenge for clinical trials by Catani, João Paulo Portela, Riechelmann, Rachel P., Adjemian, Sandy, Strauss, Bryan E.

    Published in Human vaccines & immunotherapeutics (04-05-2017)
    “…The success of immunotherapies brings hope for the future of cancer treatment. Even so, we are faced with a new challenge, that of understanding which patients…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells by Smet, Anouk, Catani, Joao Paulo Portela, Ysenbaert, Tine, Gonçalves, Amanda, Kleanthous, Harry, Vogel, Thorsten U, Saelens, Xavier, Job, Emma R

    Published in PloS one (31-01-2022)
    “…Influenza neuraminidase (NA) is implicated in various aspects of the virus replication cycle and therefore is an attractive target for vaccination and…”
    Get full text
    Journal Article
  15. 15

    Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists by Yamazaki, T, Hannani, D, Poirier-Colame, V, Ladoire, S, Locher, C, Sistigu, A, Prada, N, Adjemian, S, Catani, J PP, Freudenberg, M, Galanos, C, André, F, Kroemer, G, Zitvogel, L

    Published in Cell death and differentiation (01-01-2014)
    “…Immunogenic cell death induced by anticancer chemotherapy is characterized by a series of molecular hallmarks that include the exodus of high-mobility group…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma12 by Catani, João Paulo Portela, Medrano, Ruan F.V., Hunger, Aline, Del Valle, Paulo, Adjemian, Sandy, Zanatta, Daniela Bertolini, Kroemer, Guido, Costanzi-Strauss, Eugenia, Strauss, Bryan E.

    Published in Translational oncology (02-12-2016)
    “…Therapeutic strategies that act by eliciting and enhancing antitumor immunity have been clinically validated as an effective treatment modality but may benefit…”
    Get full text
    Journal Article
  18. 18

    Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells by Anouk Smet, Joao Paulo Portela Catani, Tine Ysenbaert, Amanda Gonçalves, Harry Kleanthous, Thorsten U. Vogel, Xavier Saelens, Emma R. Job

    Published in PloS one (01-01-2022)
    “…Influenza neuraminidase (NA) is implicated in various aspects of the virus replication cycle and therefore is an attractive target for vaccination and…”
    Get full text
    Journal Article